Skip to main content

iRhythm Technologies Inc

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

IRTC$86.06-3.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits, Financial Statement Schedules

The following documents are filed as part of this Annual Report on Form 10-K:

(1)Financial Statements

The financial statements filed as part of this Annual Report on Form 10-K are listed in the “Index to Financial Statements” under Part II, Item 8 of this Annual Report on Form 10-K.

(2)Financial Statement Schedules

Financial statement schedules have been omitted in this Annual Report on Form 10-K because they are not applicable, not required under the instructions, or the information requested is set forth in the financial statements or related notes thereto.

(3) Exhibits

The following is a list of exhibits filed with this Annual Report on Form 10-K incorporated herein by reference (numbered in accordance with Item 601 of Regulation S-K).

Exhibit Index
Incorporated by Reference
ExhibitNumberExhibit TitleFormFile No.ExhibitFiling DateProvided Herewith
3.1 · Amended and Restated Certificate of Incorporation of the Registrant, as amended. · X
3.2Amended and Restated Bylaws of the Registrant (as amended and restated on November 10, 2023).8-K001-379183.1November 16, 2023
4.1Specimen Common Stock Certificate of the Registrant.S-1333-2137734.1September 23, 2016
4.2Amended and Restated Investors’ Rights Agreement dated May 16, 2014 by and among the Registrant and certain stockholders.S-1/A333-2137734.2October 7, 2016
4.3Description of the Registrant's securities registered pursuant to Section 12 of the Exchange Act.10-K001-379184.3March 2, 2020
10.1±Services Agreement dated December 24, 2013 between the Registrant and XIFIN, Inc.S-1333-21377310.20September 23, 2016
10.2±Development Collaboration Agreement dated December 3, 2019 by and among the Registrant, Verily Life Sciences LLC and Verily Ireland Limited.10-Q001-3791810.3December 23, 2019
10.3±First Amendment to Development Collaboration Agreement dated April 26, 2021 by and among the Registrant, Verily Life Sciences LLC and Verily Ireland Limited.10-K001-3791810.43February 28, 2022
10.4±Second Amendment to Revive and Amend the Development Collaboration Agreement dated January 24, 2022 by and among the Registrant, Verily Life Sciences LLC and Verily Ireland Limited.10-K001-3791810.44February 28, 2022
10.5Third Amended and Restated Loan and Security Agreement, dated as of October 23, 2018, between Silicon Valley Bank, a California corporation, and iRhythm Technologies, Inc., a Delaware corporation.8-K001-3791810.1October 29, 2018
10.6First Amendment to Third Amended and Restated Loan and Security Agreement between the Registrant and Silicon Valley Bank.10-K001-379184.4March 2, 2020
10.7Second Amendment to the Third Amended and Restated Loan and Security Agreement dated March 28, 2022, by and between the Registrant and Silicon Valley Bank.8-K001-3791810.1March 29, 2022
10.8Third Amendment to the Third Amended and Restated Loan and Security Agreement dated November 17, 2023, by and between the Registrant and Silicon Valley Bank.X
10.9Office Lease dated October 4, 2018 between the Registrant and Big Dog Holdings LLC.10-K001-3791810.35March 4, 2019
10.10First Amendment to Office Lease dated May 31, 2019 between the Registrant and Big Dog Holdings LLC.X
10.11Multi-Tenant Office/Industrial Lease by and between iRhythm Technologies, Inc. and Katella/Holder Street LLC dated March 18, 2021.10-Q001-3791810.42May 10, 2021
10.12Credit, Security and Guaranty Agreement, dated January 3, 2024, by and among the Company, Braidwell Transaction Holdings LLC – Series 5 and Wilmington Trust, National Association.8-K001-3791810.1January 8, 2024
10.13+2016 Equity Incentive Plan and related form agreements.S-1/A333-21377310.3October 7, 2016
10.14+2016 Employee Stock Purchase Plan, as amended February 26, 2019, and related form agreements.10-Q001-3791810.1December 23, 2019
10.15+Executive Incentive Compensation Plan.S-1/A333-21377310.5October 7, 2016
10.16+Form of Indemnification Agreement for directors and executive officers.S-1333-21377310.1September 23, 2016
10.17+Executive Change in Control and Severance Policy as Amended.X
10.18+Form of Change of Control and Severance Agreement.10-Q001-3791810.29November 14, 2017
10.19+Offer Letter, dated September 8, 2021, by and between the Registrant and Quentin S. Blackford.8-K001-3791810.1September 13, 2021
10.20+Offer Letter, dated November 15, 2021, by and between the Registrant and Patrick Murphy.10-K001-3791810.19February 23, 2023
10.21+Offer Letter, dated April 24, 2022, by and between the Registrant and Minang Pravin Turakhia, MD.10-K001-3791810.20February 23, 2023
10.22+Offer Letter, dated July 18,2022, by and between the Registrant and Chad Patterson.10-K001-3791810.21February 23, 2023
10.23+Offer Letter, dated July 22, 2022, by and between the Registrant and Brice Bobzien.10-K001-3791810.22February 23, 2023
10.24+Resignation, Release and Consulting Agreement dated March 10, 2023 by and between the Registrant and Douglas Devine.10-Q001-3791810.1May 4, 2023
21.1List of Subsidiaries of Registrant.X
23.1Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, San Jose, CA, PCAOB ID: 238)X
31.1†Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2†Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1†Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
97.1Compensation Recovery PolicyX
101.INSInline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document

†The certification attached as 32.1 that accompanies this Annual Report on Form 10-K, is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of iRhythm Technologies, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.

  • Indicates management contract or compensatory plan.

± Confidential treatment has been requested for portions of this exhibit. These portions have been omitted and have been filed

separately with the Securities and Exchange Commission.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.